Functional comparison of induced pluripotent stem cell- and blood-derived GPIIbIIIa deficient platelets.

Functional comparison of induced pluripotent stem cell- and blood-derived GPIIbIIIa deficient platelets.

Human induced pluripotent stem cells (hiPSCs) represent a versatile tool to model genetic diseases and are a potential source for cell transfusion therapies. However, it remains elusive to which extent patient-specific hiPSC-derived cells functionally resemble their native counterparts. Here, we gen...

Full description

Bibliographic Details
Main Authors:	Mathias Orban, Alexander Goedel, Jessica Haas, Kirstin Sandrock-Lang, Florian Gärtner, Christian Billy Jung, Barbara Zieger, Elvira Parrotta, Karin Kurnik, Daniel Sinnecker, Gerhard Wanner, Karl-Ludwig Laugwitz, Steffen Massberg, Alessandra Moretti
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4301811?pdf=render

Similar Items

Arteriosclerosis and the promise of GPIIb/IIIa inhibitors in stroke Arteriosclerosis y nuevas perspectivas de los inhibidores del receptor GPIIb/IIIa en stroke
by: GUSTAVO SAPOSNIK, et al.
Published: (2000-03-01)

Design and development of ICCA as a dual inhibitor of GPIIb/IIIa and P-selectin receptors
by: Chen H, et al.
Published: (2018-07-01)

Lack of influence of the COX inhibitors metamizol and diclofenac on platelet GPIIb/IIIa and P-selectin expression <it>in vitro</it>
by: Gröschel Werner, et al.
Published: (2004-04-01)

Platelets induce apoptosis during sepsis in a contact-dependent manner that is inhibited by GPIIb/IIIa blockade.
by: Matthew Sharron, et al.
Published: (2012-01-01)

Deep Vein Thrombosis Is Facilitated by Endothelial-Derived Extracellular Vesicles via the PDI–GRP94–GPIIb/IIIa Pathway in Mice
by: Hongtao Lan, et al.
Published: (2023-06-01)

Novel Thrombolytic Drug Based on Thrombin Cleavable Microplasminogen Coupled to a Single‐Chain Antibody Specific for Activated GPIIb/IIIa
by: Thomas Bonnard, et al.
Published: (2017-02-01)

Human platelet antigen 1a epitopes are dependent on the cation-regulated conformation of integrin α(IIb)β(3) (GPIIb/IIIa).
by: Allen, D, et al.
Published: (2012)

Human platelet antigen 1a epitopes are dependent on the cation-regulated conformation of integrin α(IIb)β(3) (GPIIb/IIIa).
by: Allen, D, et al.
Published: (2012)

Platelet Activation in Ovarian Cancer Ascites: Assessment of GPIIb/IIIa and PF4 in Small Extracellular Vesicles by Nano-Flow Cytometry Analysis
by: Barbara Bortot, et al.
Published: (2022-08-01)

Platelet surface GPIbα, activated GPIIb-IIIa, and P-selectin levels in adult veno-arterial extracorporeal membrane oxygenation patients
by: Michael Mazzeffi, et al.
Published: (2022-01-01)

Ticagrelor washout bridged with GPIIb/IIIa inhibitor infusion to facilitate surgical care following placement of pipeline flow diverters: a case report
by: Aaron Zweig, et al.
Published: (2023-06-01)

Introduction of direct-acting antiviral agents alters frequencies of anti-GPIIb/IIIa antibody-producing B cells in chronic hepatitis C patients with thrombocytopenia
by: Takashi Satoh, et al.
Published: (2023-12-01)

Decreased Platelet Specific Receptor Expression of P-Selectin and GPIIb/IIIa Predict Future Non-Surgical Bleeding in Patients after Left Ventricular Assist Device Implantation
by: Kristin Klaeske, et al.
Published: (2022-09-01)

Case report: Early thrombosis in left atrial during transcatheter closure of ASD in a child with favorable outcome after use of GPIIb/IIIa receptor antagonist and heparin
by: Hui Wang, et al.
Published: (2023-03-01)

Gli antagonisti del recettore GPIIb/IIIa: farmacologia, clinica ed economia nelle sindromi coronariche acute NSTEMI e nelle rivascolarizzazioni per via percutanea
by: Lorenzo Pradelli
Published: (2005-12-01)

Platelet GPIIb supports initial pulmonary retention but inhibits subsequent proliferation of melanoma cells during hematogenic metastasis.
by: Katrin Echtler, et al.
Published: (2017-01-01)

Development of the Integrated Computer Simulation Model of the Intracellular, Transmembrane, and Extracellular Domain of Platelet Integrin α<sub>IIb</sub>β<sub>3</sub> (Platelet Membrane Glycoprotein: GPIIb–IIIa)
by: Masamitsu Nakayama, et al.
Published: (2024-01-01)

High-throughput optical action potential recordings in hiPSC-derived cardiomyocytes with a genetically encoded voltage indicator in the AAVS1 locus
by: Fangfang Zhang, et al.
Published: (2022-10-01)

GPIIB ALLELIC POLYMORPHISM AS A FACTOR ASSOCIATED WITH THE PROBABILITY OF IMMUNE THROMBOCYTOPENIA AND THE SEVERITY OF HEMORRHAGIC SYNDROME
by: I. I. Zotova, et al.
Published: (2018-07-01)

Risk Prediction After Myocardial Infarction by Cyclic Variation of Heart Rate, a Surrogate of Sleep-Disordered Breathing Assessed From Holter ECGs
by: Xu Cao, et al.
Published: (2020-01-01)

Impaired neural differentiation of MPS IIIA patient induced pluripotent stem cell-derived neural progenitor cells
by: Rebecca J. Lehmann, et al.
Published: (2021-12-01)

Generation of heterozygous (MRli003-A-5) and homozygous (MRli003-A-6) voltage-sensing knock-in human iPSC lines by CRISPR/Cas9 editing of the AAVS1 locus
by: Fangfang Zhang, et al.
Published: (2022-05-01)

Antisense‐mediated exon skipping: a therapeutic strategy for titin‐based dilated cardiomyopathy
by: Michael Gramlich, et al.
Published: (2015-05-01)

Modeling Cardiac Disease Mechanisms Using Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Progress, Promises and Challenges
by: Elvira Immacolata Parrotta, et al.
Published: (2020-06-01)

Enhancing the Therapeutic Potential of Sulfamidase for the Treatment of Mucopolysaccharidosis IIIA
by: Nicolina Cristina Sorrentino, et al.
Published: (2019-12-01)

Auto-immune thrombocytopenia after Measles Mumps Rubella MMR vaccination: molecular mimicry of measles virus phosphoprotein with platelet gpIIb
by: Gerbaud Laurent, et al.
Published: (2010-05-01)

Glycoprotein IIIa Preparation for T-cell Stimulation
by: GR Anani Sarab, et al.
Published: (2005-03-01)

Glycoprotein IIIa Preparation for T-cell Stimulation
by: GR Anani Sarab, et al.
Published: (2005-10-01)

Inibidores da glicoproteína IIb/IIIa na prática clínica Inhibidores de la glicoproteína IIb/IIIa en la práctica clínica Glycoprotein IIb/IIIa inhibitors in clinical practice
by: Felipe Maia, et al.
Published: (2009-01-01)

Letter to the Editor. Response to “Diagnosis of CAV in OCT Scans From Heart Transplanted Patients”
by: Madeleine Orban, MD, et al.
Published: (2022-06-01)

Combined extracorporeal membrane oxygenation and microaxial pump—when left ventricular preload is too low to unload in cardiogenic shock
by: Enzo Lüsebrink, et al.
Published: (2021-09-01)

Ultrasonographic findings of type IIIa biliary atresia
by: Seung-seob Kim, et al.
Published: (2014-10-01)

Designer pigs for xenogeneic heart transplantation and beyond
by: Eckhard Wolf, et al.
Published: (2023-05-01)

GENE THERAPY IN MUCOPOLYSACCHARIDOSIS TYPE IIIA: CASE REPORTS
by: Benjamin Lah, et al.
Published: (2022-05-01)

Group IIIA/IVA monochalcogenides nanosheets for ultrafast photonics
by: Mengyu Zhang, et al.
Published: (2019-09-01)

Deciphering the Role of Wnt and Rho Signaling Pathway in iPSC-Derived ARVC Cardiomyocytes by In Silico Mathematical Modeling
by: Elvira Immacolata Parrotta, et al.
Published: (2021-02-01)

A new hERG allosteric modulator rescues genetic and drug‐induced long‐QT syndrome phenotypes in cardiomyocytes from isogenic pairs of patient induced pluripotent stem cells
by: Luca Sala, et al.
Published: (2016-09-01)

Immunotherapy utilization in stage IIIA melanoma: less may be more
by: Alexander E. Frey, et al.
Published: (2024-02-01)

An immune deficient mouse model for mucopolysaccharidosis IIIA (Sanfilippo syndrome)
by: Kari Pollock, et al.
Published: (2023-10-01)

Neurocognitive testing in a murine model of mucopolysaccharidosis type IIIA
by: Kleopatra Pericleous, et al.
Published: (2023-09-01)